Decline in blood platelet count associated with increased risk of HIV-related dementiaSeptember 11, 2007HIV patients with declining platelet counts appear to be at increased risk for HIV-associated dementia, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. "Human immunodeficiency virus-associated dementia (HIV-D) is a syndrome encompassing a spectrum of cognitive, behavioral and motor deficits that usually has an insidious onset and a chronic progressive course," the authors write as background information in the article. Therapies leading to longer life for HIV patients have paradoxically increased the prevalence of this condition. Identifying biological markers for the development of HIV-associated dementia is critical both for diagnosing the disorder and for understanding its underlying mechanisms. Lynn M. Wachtman, D.V.M., M.P.H., of Bloomberg School of Public Health, The Johns Hopkins University School of Medicine, Baltimore, and colleagues studied 396 patients with advanced HIV who were recruited for this prospective study between 1998 and 2003. Participants were examined every six months and completed mental and physical evaluations. Blood samples were also collected and assessed for platelet count (the number of clotting cells in the blood), hemoglobin levels, CD4 lymphocyte count (a measure of certain types of white blood cells, which reflects the state of the immune system) and plasma HIV RNA levels (which indicate the amount of "viral load," and predict HIV progression).
After a median (midpoint) follow-up of 31.1 months, 40 participants developed HIV-associated dementia. A decline in platelet count from baseline was associated with the development of dementia within six to 12 months. "Those HIV-infected individuals with a decline in platelets from baseline values at this lagged time point had a two-fold increased risk of dementia" in several different analyses, the authors write. The specific timing of the association indicates that the levels of circulating platelets fluctuate as HIV-associated dementia develops, they note. "Further analyses indicated that decline from baseline platelet levels was associated with a five- to six-fold increased risk of dementia during the first two years of follow-up, but it was not associated with an increased risk of dementia after two years," the authors continue. "It is possible that individuals who do not progress rapidly to neurologic compromise differ in respect to immune activation, treatment adherence or virologic control relative to those who develop dementia more rapidly." "Because CD4 cell counts and HIV RNA levels have proven not to be predictive of HIV-associated dementia, it is important to investigate alternative serum and hematologic markers," the authors conclude. "Should these markers be routinely measured in a clinical setting, such as platelet counts, they may prove useful for patient management. This study identifies a significant association between platelet decline and incident HIV-associated dementia." Further study of platelet levels during HIV-associated dementia may lead both to a specific marker for the development of HIV-associated dementia and a better understanding of how the disease develops. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Dementia Current Events and Dementia News Articles Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline Moderate drinkers often have lower risks of Alzheimer's disease and other cognitive loss, according to researchers who reviewed 44 studies. In more than half of the studies, published since the 1990s, moderate drinkers of wine, beer and liquor had lower dementia risks than nondrinkers. Aging brains allow negative memories to fade It turns out there's a scientific reason why older people tend to see the past through rose-coloured glasses. A University of Alberta medical researcher, in collaboration with colleagues at Duke University, identified brain activity that causes older adults to remember fewer negative events than their younger counterparts. Cholinesterase inhibitors reduce aggression, wandering and paranoia in Alzheimer's disease Cholinesterase inhibitors, used to treat cognitive symptoms of Alzheimer's disease, are also a safe and effective alternative therapy for the behavioral and psychological symptoms of dementia, according to a study that appears in the December 2008 edition of Clinical Interventions in Aging. Maintaining the brain's wiring in aging and disease Researchers at the Babraham Institute near Cambridge, supported by the Alzheimer's Research Trust and the Biotechnology and Biological Sciences Research Council (BBSRC), have discovered that the brain's circuitry survives longer than previously thought in diseases of ageing such as Alzheimer's disease. Mix of taiji, cognitive therapy and support groups benefits those with dementia Those diagnosed with early stage dementia can slow their physical, mental and psychological decline by taking part in therapeutic programs that combine counseling, support groups, Taiji and qigong, researchers report. Some of the benefits of this approach are comparable to those achieved with anti-dementia medications. Study sheds light on causes of HIV dementia A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. M.I.N.D. Institute researchers call for fragile X testing throughout the lifespan Writing in this week's Journal of the American Medical Association, UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages. Bittersweet milestones For many of the elderly, the golden years are anything but. Faced with health problems, financial issues and the death of a spouse or loved one, many adults 65 years and older suffer from depression. While research is emerging to help this group understand and treat the problem, another group - centenarians - has been left largely in the dark. Rapid Screening Test Developed to Detect Early Alzheimer's Disease With millions of baby boomers entering late adulthood, the number of patients with Alzheimer's disease (AD) is expected to drastically rise over the next several decades. Caring for the caregiver: Redefining the definition of patient One quarter of all family caregivers of Alzheimer's disease patients succumb to the stress of providing care to a loved one and become hospital patients themselves, according to an Indiana University study published in the November 2008 issue of the Journal of General Internal Medicine. More Dementia Current Events and Dementia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||